Implantable Shock Absorbers for Knee osteoarthritis.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Moximed develops and distributes unicompartmental load absorber implants for active patients suffering from knee osteoarthritis. The Company provides a joint preserving/unloading therapy – the Atlas Knee System, an implantable joint unloader.
Moximed Funding
Sign up to gain insights into Moximed funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series D | Aug 07, 2024 | 63M | ||
| Series C | Mar 15, 2017 | 50M | ||
| Series B | May 07, 2015 | 13M | ||
| Series B | Apr 23, 2015 | 20M | ||
| Series A | Dec 05, 2011 | 3M | ||
| Series A | May 26, 2011 | 43M | ||
| Series A | Aug 05, 2009 | 10M | ||
| Series A | Jun 09, 2008 | 2M | ||
| Series A | Apr 15, 2008 | 19M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Moximed Management Team
Investors
Advent Life Sciences
Cormorant Asset Management
Elevage Medical Technologies
Frazier Healthcare Ventures
Future Fund
GBS Venture Partners Pty Ltd
Gilde Healthcare Partners BV
Morgenthaler Ventures
New Enterprise Associates Inc (NEA)
Vertex Venture Holdings, Ltd.
Vertex Ventures
Warren Point Capital
Moximed Valuations & Financials
View real-time NPM data on Moximed stock including daily Moximed stock price estimates, valuation history, and historical share price information. Access Moximed financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Moximed pricing across six independent market signals. Looking for private company due diligence data sources on Moximed? Get in touch to learn more.
Similar Companies
like Moximed
NeuCyte
Healthcare & Life Sciences
Accelerates neurological-disease therapy development by supplying human neural-cell tools and advanced screening platforms.
GenoPalate
Healthcare & Life Sciences
Uses DNA insights to recommend tailored dietary and supplement plans.
bttn
Healthcare & Life Sciences
B2B platform streamlines medical supply purchasing with competitive pricing and simplified procurement for healthcare professionals.
Spiral Therapeutics
Healthcare & Life Sciences
Delivers which enable targeted inner-ear therapy using minimally invasive, sustained-release drug delivery for balance and hearing conditions.
Athos Therapeutics
Healthcare & Life Sciences
Develop therapies that leverage AI and omics data to target inflammatory and autoimmune diseases with precision small molecules.
Lumafield
Healthcare & Life Sciences
Develops 3D X-ray imaging technology that improves manufacturing quality control by detecting defects and visualizing internal structures.
Imbria Pharmaceuticals
Healthcare & Life Sciences
Develops therapies that improve cardiac energy metabolism to treat heart failure and related cardiometabolic diseases.
Coologics
Healthcare & Life Sciences
Develops drug-free cooling device technology for treating vaginal infections, offering sustainable alternatives to antibiotics for women's health.
Valora Therapeutics
Healthcare & Life Sciences
Decode interactions that guide immune communication via sugar codes to unlock immunotherapies with new targeting strategies.
FAQ
We have answers
Moximed stock does not trade on public stock exchanges. Moximed stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Moximed stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Moximed Stock does not trade on public stock exchanges. In order to sell Moximed shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Moximed does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Moximed share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Moximed stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Moximed stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Moximed stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Moximed is a private company and has not had an IPO. There is currently no Moximed IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Moximed IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
